Bank Of New York Mellon Corp Dbv Technologies S.A. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$7.58 - $10.0 $9.6 Million - $12.7 Million	-1,266,810 Reduced 89.15%	154,197 $1.27 Million
Q1 2019 May 14, 2019	SELL	$5.81 - $9.37 $1.3 Million - $2.1 Million	-223,993 Reduced 13.62%	1,421,007 $11 Million
Q4 2018 Feb 11, 2019	BUY	$5.75 - $21.85 $7.28 Million - $27.7 Million	1,266,041 Added 334.08%	1,645,000 $10.6 Million
Q3 2018 Nov 09, 2018	BUY	$16.81 - $24.58 $6.37 Million - $9.31 Million	378,959 New	378,959 $0

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $1.67B
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.